Deka Bank Deutsche Girozentrale Karuna Therapeutics, Inc. Transaction History

Deka Bank Deutsche Girozentrale

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	BUY	$161.01 - $317.85 $243,125 - $479,953	1,510 Added 8.17%	20,000 $6.33 Million
Q3 2023 Nov 13, 2023	BUY	$164.66 - $218.08 $80,683 - $106,859	490 Added 2.72%	18,490 $3.11 Million
Q3 2022 Nov 02, 2022	SELL	$123.79 - $277.42 $266,148 - $596,453	-2,150 Reduced 10.67%	18,000 $4.08 Million
Q2 2022 Aug 03, 2022	BUY	$93.97 - $143.33 $986,685 - $1.5 Million	10,500 Added 108.81%	20,150 $2.52 Million
Q1 2022 Apr 28, 2022	BUY	$98.9 - $132.37 $89,010 - $119,133	900 Added 10.29%	9,650 $1.19 Million
Q4 2021 Feb 02, 2022	BUY	$110.64 - $159.4 $27,660 - $39,850	250 Added 2.94%	8,750 $1.15 Million
Q4 2020 Mar 12, 2021	SELL	$75.23 - $109.23 $30,092 - $43,692	-400 Reduced 4.49%	8,500 $867,000
Q3 2020 Oct 29, 2020	BUY	$71.31 - $109.74 $634,659 - $976,686	8,900 New	8,900 $703,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.